The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
P. A. Gallay, W. Stauffer, M. Bobardt, D. Ure, R. Foster
This study shows that rencofilstat reduces HCV-induced HCC independently of its antiviral activity, making it a potential therapeutic agent for HCC.
bioRxiv · Aug 19, 2023Microbiology